Alzheimer’s is a cruel disease that cannot be prevented, cured or slowed… yet. Scientists are hard at work on new treatments for dementia that are projected to be available by 2025. So far treatments have only been able to target Alzheimer’s symptoms, but now scientists are finding ways to slow or even stop the disease’s progression. Two new drugs called solanezumab and aducanumab- antibody infusions that destroy plaque buildup in the brain- are currently undergoing clinical trials, and have thus far shown promising results. These are the first drugs that truly target the root cause of Alzheimer’s, not just the symptoms.
Today, one in three seniors dies with Alzheimer’s or another form of dementia. A decade from now, these figures could be a part of history we’ve left behind. Imagine a world without dementia; where so much fear about aging would be a thing of the past. Researchers believe that an inexpensive, once-daily pill to treat Alzheimer’s is on the horizon that will make the disease manageable and allow for years of continued mental functioning. Experts assert that a five year delay in the progression of dementia will reduce its death rate by approximately half.
Professor John Hardy of the Institute of Neurology at University College London believes that 2016 will prove whether we are on the brink of “a new era of better treatments for slowing or stopping the development of Alzheimer’s disease.” He goes on to say: “I think we will get to a situation where we will manage it in the way we manage diabetes now. I see a day where dementia will not be a major issue.”
Today, one in three seniors dies with Alzheimer’s or another form of dementia. A decade from now, these figures could be a part of history we’ve left behind. Imagine a world without dementia; where so much fear about aging would be a thing of the past. Researchers believe that an inexpensive, once-daily pill to treat Alzheimer’s is on the horizon that will make the disease manageable and allow for years of continued mental functioning. Experts assert that a five year delay in the progression of dementia will reduce its death rate by approximately half.
Professor John Hardy of the Institute of Neurology at University College London believes that 2016 will prove whether we are on the brink of “a new era of better treatments for slowing or stopping the development of Alzheimer’s disease.” He goes on to say: “I think we will get to a situation where we will manage it in the way we manage diabetes now. I see a day where dementia will not be a major issue.”
RSS Feed
